Ongoing Proton Pump Inhibitor Litigation
In June 2018, the plaintiff’s counsel for the ongoing Proton Pump Inhibitor (PPI) MDL No. 2789 tolled the statute of limitations, give them more time to investigate the factual basis of PPI kidney injury claims. The details of the agreement can be found in the official court filing, linked above. There are currently more than 4,000 lawsuits filed in federal court against PPI manufacturers for kidney damage patients experienced while taking PPIs like Prilosec and Nexium.
What is Dangerous About Proton Pump Inhibitors?
PPIs have been linked to causing serious kidney complications, including:
- Acute interstitial nephritis
- Kidney disease
- Kidney failure.
Lawsuits filed against PPI manufacturers claim that they were aware of the dangerous relationship between PPIs and kidney injuries. In 1992, the American Journal of Medicine published a medical study linking PPI use to kidney injuries.
When is the First Proton Pump Inhibitor MDL Lawsuit Going to Trial?
The first PPI bellwether trial is set for September 2020. Bellwether trials are designed to serve as an example of how the thousands of proton pump inhibitors filed may be handled. From bringing light to the main issues associated with PPIs, to possibly shaping the way manufacturers decide to settle these cases, it is highly anticipated as to how these lawsuits will be handled.
It is important to keep in mind that proton pump inhibitor lawsuits are in the very early stages of litigation. It can take months, and sometimes years to fully prepare a case for trial. If you or someone you love has experienced kidney damage after taking a PPI, contact your physician today to see what options are best for you.
Which Proton Pump Inhibitor Manufacturers Have Been Named in the Lawsuits?
The following PPI manufacturers have had lawsuits filed against them for damages associated with their respective medication:
- Proctor & Gamble
- Takeda Pharmaceuticals.
The Future of Proton Pump Inhibitor Lawsuits
As mentioned above, the lawsuits filed against PPI manufacturers are in the very early stages of development. This is also apparent by the defense counsel agreeing to toll the SOL for individuals filing lawsuits against PPI manufacturers. The court filing linked above explains that the defense counsel agreed to the tolling, “voluntarily and as the product of negotiations with Plaintiffs’ counsel given what is known (and not known) about the usage of PPIs and the filings to date in these MDL proceedings and in related state court litigation.”
To stay updated on proton pump inhibitor litigation, follow us on social media and check out our blog. Product liability lawsuits are filed frequently against negligent manufacturers and we are here to keep you informed.